1. “Recombinant Antibody Production Using a Dual-Promoter Single Plasmid System”
by Stefania C. Carrara, David Fiebig, Jan P. Bogen, Julius Grzeschik, Björn Hock and Harald Kolmar
Antibodies 2021, 10(2), 18; https://doi.org/10.3390/antib10020018
Available online: https://www.mdpi.com/2073-4468/10/2/18

2. “Construction of a Humanized Artificial VHH Library Reproducing Structural Features of Camelid VHHs for Therapeutics”
by Taihei Murakami, Shigefumi Kumachi, Yasuhiro Matsunaga, Miwa Sato, Kanako Wakabayashi-Nakao, Hidekazu Masaki, Ryo Yonehara, Maiko Motohashi, Naoto Nemoto and Masayuki Tsuchiya
Antibodies 2022, 11(1), 10; https://doi.org/10.3390/antib11010010
Available online: https://www.mdpi.com/2073-4468/11/1/10

3. “Glycoengineering of Therapeutic Antibodies with Small Molecule Inhibitors”
by Shasha Li, Alex J. McCraw, Richard A. Gardner, Daniel I. R. Spencer, Sophia N. Karagiannis and Gerd K. Wagner
Antibodies 2021, 10(4), 44; https://doi.org/10.3390/antib10040044
Available online: https://www.mdpi.com/2073-4468/10/4/44

4. “HDX-MS for Epitope Characterization of a Therapeutic ANTIBODY Candidate on the Calcium-Binding Protein Annexin-A1”
by Marius Gramlich, Henry C. W. Hays, Scott Crichton, Philipp D. Kaiser, Anne Heine, Nicole Schneiderhan-Marra, Ulrich Rothbauer, Dieter Stoll, Sandra Maier and Anne Zeck
Antibodies 2021, 10(1), 11; https://doi.org/10.3390/antib10010011
Available online: https://www.mdpi.com/2073-4468/10/1/11

5. “The Role of Bispecific Antibodies in Non-Hodgkin’s Lymphoma: From Structure to Prospective Clinical Use”
by Rita Tavarozzi and Enrica Manzato
Antibodies 2022, 11(1), 16; https://doi.org/10.3390/antib11010016
Available online: https://www.mdpi.com/2073-4468/11/1/16

6. “Pharmacokinetic Developability and Disposition Profiles of Bispecific Antibodies: A Case Study with Two Molecules”
by Amita Datta-Mannan, Robin Brown, Stephanie Key, Paul Cain and Yiqing Feng
Antibodies 2022, 11(1), 2; https://doi.org/10.3390/antib11010002
Available online: https://www.mdpi.com/2073-4468/11/1/2

7. “Central Nervous System Delivery of Antibodies and Their Single-Domain Antibodies and Variable Fragment Derivatives with Focus on Intranasal Nose to Brain Administration”
by Arghavan Soleimanizadeh, Heiko Dinter and Katharina Schindowski
Antibodies 2021, 10(4), 47; https://doi.org/10.3390/antib10040047
Available online: https://www.mdpi.com/2073-4468/10/4/47

8. “Functional Changes of Therapeutic Antibodies upon Exposure to Pro-Oxidative Agents”
by Maxime Lecerf, Robin Lacombe, Alexia Kanyavuz and Jordan D. Dimitrov
Antibodies 2022, 11(1), 11; https://doi.org/10.3390/antib11010011
Available online: https://www.mdpi.com/2073-4468/11/1/11